' Impressive Results ' From Stage III Melanoma Studies: ASCO 2020 ' Impressive Results ' From Stage III Melanoma Studies: ASCO 2020

Dr Jeffrey Weber describes three adjuvant and/or neoadjuvant studies in stage III melanoma that piqued his interest at this year ' s American Society of Clinical Oncology virtual meeting.Medscape Oncology

Source: Medscape General Surgery Headlines - August 25, 2020 Category: Surgery Tags: Hematology-Oncology Commentary Source Type: news